Vistin Pharma — Director's Dealing 2024

Mar 22, 2024

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA

at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in

Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA.

Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are

sold to one of Pactum's shareholders, as part of a share buy-back process in

Pactum.

After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma

ASA.

Please see attached document in accordance with the Market Abuse Regulation

article 19.

This notification has been submitted pursuant to the Securities Trading Act

section 5-12.